MELBOURNE, Australia, April 17, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today provides an update on its revenue and operational performance for the...
FDA Fast Track designation granted for TLX101-CDx for glioma (brain cancer) imagingCollaboration agreement announced for joint development and commercialisation with UCSF PharmaLogic announced as...
Telix Pharmaceuticals Limited completes the acquisition of ARTMS, Inc.
World First Use of Lightpoint`s SENSEI® Drop-In Gamma Probe in Surgery
First Patient Dosed in Italian Named Patient Program for TLX250-CDx
MELBOURNE, Australia and DRESDEN, Germany, March 19, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into an agreement to...
Appointment of Dr Darren Patti to Group Chief Operating Officer
Telix takes on isotope manufacturer ARTMS for up to $82M
Telix to Acquire ARTMS, Inc. and its Advanced Isotope Production Platform
Welcome to Endpoints News’ manufacturing briefs, where we bring you essential updates on new builds, collaborations, recalls and more.